No more charging: new implant aims to ease bladder and bowel leaks

NCT ID NCT06186765

Ongoing Disease control Sponsor: Axonics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 4 times

Summary

This study is testing a new, recharge-free nerve stimulator (Axonics SNM system) in 144 adults with overactive bladder or fecal incontinence. The device is implanted to stimulate sacral nerves and improve control. Researchers will measure quality of life and symptom changes over one year, along with safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Axonics recharge-free sacral neuromodulation (SNM) system (Model 4101)
What this could lead to: If successful, this device could offer a more convenient, long-term option for managing bladder and bowel control without needing to recharge the implant.
What could go wrong: This is a single-arm, non-randomized study with no placebo group, so results may be less reliable. The device may not work for everyone, and risks include infection or device-related complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FECAL INCONTINENCE (FI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fecal Incontinence overactive bladder Urinary Incontinence, Urge

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FECAL INCONTINENCE (FI) URINARY FREQUENCY (UF) URINARY URGE INCONTINENCE (UUI)

Contacts and locations

Locations

Adult Pediatric Urology & Urogynecology

Omaha, Nebraska, 68114, United States
Atrium Health

Macon, Georgia, 31201, United States
Bristol Urological Institute

Bristol, BS105NB, United Kingdom
Columbia University Medical Center

New York, New York, 10032, United States
East Coast Institute of Research

Jacksonville, Florida, 32216, United States
Erasmus Medical Center

Rotterdam, Netherlands
Florida Bladder Institute

Naples, Florida, 34109, United States
Florida Gulf Clinical Research

Bradenton, Florida, 34205, United States
Hartford Healthcare

Waterford, Connecticut, 06385, United States
Houston Colon

Houston, Texas, 77030, United States
Minnesota Urology

Coon Rapids, Minnesota, 55433, United States
Northern General Hospital

Sheffield, S5 7AU, United Kingdom
Queen Elizabeth Hospital

Birmingham, B15 2TH, United Kingdom
Southern Shores Urogynecology

Myrtle Beach, South Carolina, 29572, United States
The Oregon Clinic

Portland, Oregon, 97225, United States
University College London Hospital

London, W1G 8PH, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.